Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Varex ImagingVREX +0.66%69 Days Payable is 55.77 as of Mar. 2026, which is 29% above its 10-year median of 43.39. GuruFocus rates VREX with a GF Score™ of 69/100 and a GF Value™ of $14.01 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Varex Imaging ranks worse than 66.75% on this metric.
The historical rank and industry rank for Varex Imaging's Days Payable or its related term are showing as below:
VREX'
s Days Payable Range Over the Past 10 Years
Min: 40.78 Med: 43.39 Max: 49.54
Current: 49.54
During the past 13 years, Varex Imaging's highest Days Payable was 49.54. The lowest was 40.78. And the median was 43.39.
VREX's Days Payable is ranked worse than 66.75% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs VREX: 49.54
Varex Imaging's Days Payable
increased
from Mar. 2025 (45.69) to Mar. 2026 (55.77).
It may suggest that Varex Imagingdelayed paying its suppliers.
Varex Imaging Days Payable Related Terms
Varex Imaging Days Payable Historical Data
* Premium members only.
The historical data trend for Varex Imaging's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Varex Imaging's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Varex Imaging Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Varex Imaging's Days Payable distribution charts can be found below:
* The bar in red indicates where Varex Imaging's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Varex Imaging's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Varex Imaging (VREX) has a Days Payable of 55.77 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Varex Imaging and its competitors. This is 29% above median its historical median of 43.39. Over the past decade, Varex Imaging's Days Payable has ranged from 40.78 to 49.54. According to the industry distribution chart, Varex Imaging ranks #530 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 66.8%.
Is Varex Imaging's Days Payable too high?
Varex Imaging's current Days Payable of 55.77 is 29% above median its 10-year median of 43.39. Over the past 10 years, this metric has ranged from a low of 40.78 to a high of 49.54. The Medical Devices & Instruments industry median Days Payable is 67.97. Varex Imaging's value of 55.77 is 17.9% below this industry median. Based on the distribution chart, Varex Imaging ranks #530 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Varex Imaging has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Varex Imaging's Days Payable compare to VMD and DCTH?
According to the Medical Devices & Instruments industry distribution chart, Varex Imaging ranks #530 out of 794 companies for Days Payable. This places Varex Imaging in the lower half of its industry. The industry median Days Payable is 67.97. Varex Imaging's value of 55.77 is 17.9% below this benchmark. Historically, Varex Imaging's own Days Payable has ranged from 40.78 to 49.54 over the past decade. While the company's 10-year median is 43.39 vs. the industry median of 67.97, Varex Imaging has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Varex Imaging's current Days Payable of 55.77 is 17.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Varex Imaging and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Varex Imaging's current Days Payable is 55.77, which is 29% above median its own 10-year median of 43.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Varex Imaging stock overvalued right now?
Based on GuruFocus' analysis, Varex Imaging (VREX) is currently considered Modestly Undervalued. The stock's GF Value™ is $14.01, compared to a current price of $10.63 — trading 24.1% below its estimated fair value. The current Days Payable is 55.77, which is 29% above median its 10-year median of 43.39 and 17.9% below the Medical Devices & Instruments industry median of 67.97. Varex Imaging's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Varex Imaging (VREX), the current Days Payable is 55.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Varex Imaging (VREX) Overvalued in 2026?
Based on GuruFocus' analysis, Varex Imaging stock appears to be undervalued.
The current stock price of $10.63 is trading 24.1% below its estimated GF Value™ of $14.01.
GuruFocus considers Varex Imaging to be Modestly Undervalued.
Key valuation signals for VREX:
Days Payable: 55.77 (29% above median its 10-year median of 43.39)
GF Value™: $14.01 vs. price of $10.63 (24.1% below fair value)
Industry Position: 17.9% below the Medical Devices & Instruments median (#530 of 794)
No single metric tells the full story. See the VREX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
69GF Score
Get the complete analysis for VREX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VREX has been successfully added to your 
